Affilogic is a biotech company developing a new class of proprietary affinity ligands: Nanofitins®
Nanofitins® are able to selectively bind a wide range of targets and have proven excellent tools for:
- Targeting (immunolocalization, in vivo neutralization)
- Capture (affinity chromatography, protein removal,…)
- Detection (immunoassays, Western Blot,…)
Nanofitins® constitute a robust and affordable alternative to antibodies.
Meet us
- CALBIO 2013 June, 12-14 2013
- French Biotech Tour : Immunology & Oncology June 6, 2013
Latest news
- Nanofitins®, drugs of the future… April 4, 2013
- Presenting @ BioPartneringNorthFebruary 26, 2013
Discussion forum
Any question or comment on
Nanofitins® ?
Let us know by leaving a message.